Inactivation of ID4 Promotes a CRPC Phenotype with Constitutive AR Activation Through FKBP52

Joshi, Jugal Bharat, Clark Atlanta University
Patel, Divya, Clark Atlanta University
Morton, Derrick J., Clark Atlanta University
Sharma, Pankaj, Clark Atlanta University
Zou, Jin, Clark Atlanta University
Bostanthirige, Dhanuska Hewa, Clark Atlanta University
Gorantla, Yamini, Mercer University
Nagappan, Peri, Clark Atlanta University
Komaragiri, Shravan Kumar, Clark Atlanta University
Sivils, Jeffrey C., University of Texas at El Paso
Xie, Huan, Texas Southern University
Palaniappan, Ravi, Mercer University

2017-04-01

2010-2019

Castration-resistant prostate cancer (CRPC) is the emergence of prostate cancer cells that have adapted to the androgen-depleted environment of the prostate. In recent years, targeting multiple chaperones and co-chaperones (e.g., Hsp27, FKBP52) that promote androgen receptor (AR) signaling and/or novel AR regulatory mechanisms have emerged as promising alter- native treatments for CRPC. We have shown that inactivation of inhibitor of differentiation 4 (ID4), a dominant-negative helix loop helix protein, promotes de novo steroidogenesis and CRPC with a gene expression signature that resembles constitutive AR activity in castrated mice. In this study, we investigated the underlying mechanism through which loss of ID4 potentiates AR signaling. Proteomic analysis between prostate cancer cell line LNCaP (L+ns) and LNCaP lacking ID4 (L(?)ID4) revealed elevated levels of Hsp27 and FKBP52, suggesting a role for these AR-associated co- chaperones in promoting constitutively active AR signaling in L(?)ID4 cells. Interestingly, protein interaction studies demonstrated a direct interaction between ID4 and the 52-kDa FK506-binding protein (FKBP52) in vitro, but not with AR. An increase in FKBP52-dependent AR transcriptional activity was observed in L(?)ID4 cells. Moreover, pharmacological inhibition of FKBP52-AR signaling, by treatment with MJC13, attenuated the tumor growth, weight, and volume in L(?)ID4 xenografts. Together, our results demonstrate that ID4 selectively regulates AR activity through direct interaction with FKBP52, and its loss, promotes CRPC through FKBP52-mediated AR signaling.

text

application/pdf

articles

Molecular Oncology

Clark Atlanta University

10.1002/1878-0261.12028

http://hdl.handle.net/20.500.12322/cau.ir:2017_Joshi_et_al

http://rightsstatements.org/vocab/InC/1.0/